Paul Averback
Vermogen: 4 M $ op 30-06-2025
Vermogen: 4 M $ op 30-06-2025
Paul Averback is the founder of Nymox Pharmaceutical Corp.
since 1995, holding the title of Co-Chairman, President & Chief Executive Officer.
Former job includes President at DMS Pharmaceutical Group, Inc. Education includes a doctorate from the University of Cambridge, conferred in 1975.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 19-04-2025 | 35.008.010 ( 37,43% ) | 4 M $ | 30-06-2025 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NYMOX PHARMACEUTICAL CORPORATION | Algemeen Directeur | 30-09-1995 |
| Bedrijven | Functie | Einde |
|---|---|---|
DMS Pharmaceutical Group, Inc.
DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services Supplies pharmaceutical products | President | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Nymox Pharmaceutical Corp.
Nymox Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which specializes in the research and development of products for the aging population | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DMS Pharmaceutical Group, Inc.
DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau